Karen Zaderej, Chairman, CEO, and President at Axogen Inc. discusses the development and commercialization of technologies for peripheral nerve regeneration and repair that can restore nerve function and quality of life to patients using innovative, clinically proven, and economically effective solutions. This allows clinicians to repair damaged nerves more efficiently than current standard-of-care procedures, with fewer potential complications and similar or better outcomes. The company has dedicated significant resources to increasing patient awareness and education by amplifying the voices of patients through its Patient Ambassador program and it is also committed to educating clinicians about emerging best practices in peripheral nerve repair, organizing training programs for surgeons each year.
Ms. Zaderej joined Axogen Corporation in May 2006. Karen has served as President, Chief Executive Officer and a Member of the Board of Directors since September 2011 and became Chairman of the Board of Directors in May 2018. Karen served as Chief Executive Officer and as a member of the Board of Directors of Axogen Corporation since May 2010 and as Chief Operating Officer from October 2007 to May 2010 and as Vice President of Marketing and Sales from May 2006 to October 2007. From October 2004 to May 2006, Karen worked for Zaderej Medical Consulting, a consulting firm she founded, which assisted medical device companies build and execute successful commercialization plans. From 1987 to 2004, Karen worked at Ethicon, Inc., a Johnson & Johnson company, where she held senior positions in marketing, business development, research & development, and manufacturing. Karen is a member of the University of Tampa Board of Trustees and the MedExec Women Board of Advisors. Karen has an MBA from the Kellogg Graduate School of Business and a BS in Chemical Engineering from Purdue University.